FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387079785> ?p ?o ?g. }

• W4387079785 abstract "Abstract Background High density lipoprotein (HDL) exerts various atheroprotective functions including cholesterol efflux capacity (CEC). HDL can attenuate lipid burden at atherosclerotic lesion by CEC. Based on the HDL`s role for moderate atherosclerosis, HDL-cholesterol level which indicates the amount of HDL has been evaluated to assess the risk of cardiovascular disease (CVD). Nevertheless, many clinical studies demonstrated that HDL-cholesterol level does not always reflect the risk of CVD, and CEC which represents the quality of HDL is considered as surrogate biomarker for CVD. CEC is prospective biomarker for CVD risk assessment, however, CEC measurement encounters barriers for clinical application because of its requirements of cultured cell and radioactive substance for conventional CEC assay. To overcome these problems, we invented a novel CEC assay called immobilized liposome-bound gel beads (ILG) method. This method is cell-free assay and utilizes a fluorescence substance as cholesterol tracer. Although the ILG method is useful assay for clinical application, previous study revealed that bilirubin caused false positive error on CEC value. Hence, current ILG method might produce incorrect CEC evaluation for patients with hyperbilirubinemia and even healthy subjects within the range of biological variation of bilirubin. In this study, we improved the influence of bilirubin for ILG method by using bilirubin oxidase (BOD). Methods BOD (Asahi Kasei Corp.) was added to 10 mM Tris-HCl (pH 7.4) containing 150 mM of NaCl and 1 mM of Na2EDTA (Buffer A). Bilirubin from ‘Interference check A Plus’ (Sysmex Inc.) was added to serum (free-: 10 mg/dL, conjugated-:9.7 mg/dL), and apoB-depleted serum (BDS) was derived from the bilirubin additive serum using polyethylene glycol. After the prepared bilirubin additive BDS was incubated with BOD-containing Buffer A for 16 h, the absorbance spectrum was analyzed. In addition, the time course of bilirubin decrement was monitored during 16 h-incubation. We further measured the fluorescence intensity of bilirubin additive BDS incubated with BOD-containing Buffer A. Using the newly developed BOD-containing Buffer A for ILG method, CEC of bilirubin additive serum was evaluated. Finally, we measured CEC of 4 healthy individuals by conventional and the improved ILG method. The CEC value was standardized by fluorescence intensity of reference sample which was measured in every assay. Results BOD contained in Buffer A could convert bilirubin to biliverdin from results of absorbance spectrum. According to the time course of bilirubin decrement, both free- and conjugated-bilirubin were oxidized to biliverdin in approximately 6 h. By converting bilirubin to biliverdin, fluorescence light was weakened greatly. We confirmed that there was no significant difference of CEC values between non bilirubin-additive serum and bilirubin additive serum. Compared healthy individual CEC values measured by conventional and improved ILG method, all subjects showed significant decrease of CEC values from the improved method, and false positive error caused by bilirubin was ameliorated. Conclusion In this study, we achieved to improve the positive error caused by bilirubin on CEC assay using ILG method. This improvement would contribute to more accurate CEC assessment by ILG method and advance the clinical application of this method." @default.
• W4387079785 created "2023-09-28" @default.
• W4387079785 creator A5019721727 @default.
• W4387079785 creator A5046354994 @default.
• W4387079785 creator A5049779741 @default.
• W4387079785 creator A5056125020 @default.
• W4387079785 creator A5062452335 @default.
• W4387079785 creator A5065199371 @default.
• W4387079785 date "2023-09-27" @default.
• W4387079785 modified "2023-09-29" @default.
• W4387079785 title "A-209 Application of Bilirubin Oxidase for Improvement of False Positive Error Caused by Bilirubin on Cholesterol Efflux Capacity Assay by Immobilize Liposome-Bound Gel Beads method" @default.
• W4387079785 doi "https://doi.org/10.1093/clinchem/hvad097.188" @default.
• W4387079785 hasPublicationYear "2023" @default.
• W4387079785 type Work @default.
• W4387079785 citedByCount "0" @default.
• W4387079785 crossrefType "journal-article" @default.
• W4387079785 hasAuthorship W4387079785A5019721727 @default.
• W4387079785 hasAuthorship W4387079785A5046354994 @default.
• W4387079785 hasAuthorship W4387079785A5049779741 @default.
• W4387079785 hasAuthorship W4387079785A5056125020 @default.
• W4387079785 hasAuthorship W4387079785A5062452335 @default.
• W4387079785 hasAuthorship W4387079785A5065199371 @default.
• W4387079785 hasBestOaLocation W43870797851 @default.
• W4387079785 hasConcept C126322002 @default.
• W4387079785 hasConcept C160160445 @default.
• W4387079785 hasConcept C181199279 @default.
• W4387079785 hasConcept C185592680 @default.
• W4387079785 hasConcept C2777513400 @default.
• W4387079785 hasConcept C2777915509 @default.
• W4387079785 hasConcept C2778163477 @default.
• W4387079785 hasConcept C2779387492 @default.
• W4387079785 hasConcept C2781197716 @default.
• W4387079785 hasConcept C2909331925 @default.
• W4387079785 hasConcept C43617362 @default.
• W4387079785 hasConcept C55493867 @default.
• W4387079785 hasConcept C71924100 @default.
• W4387079785 hasConcept C98274493 @default.
• W4387079785 hasConceptScore W4387079785C126322002 @default.
• W4387079785 hasConceptScore W4387079785C160160445 @default.
• W4387079785 hasConceptScore W4387079785C181199279 @default.
• W4387079785 hasConceptScore W4387079785C185592680 @default.
• W4387079785 hasConceptScore W4387079785C2777513400 @default.
• W4387079785 hasConceptScore W4387079785C2777915509 @default.
• W4387079785 hasConceptScore W4387079785C2778163477 @default.
• W4387079785 hasConceptScore W4387079785C2779387492 @default.
• W4387079785 hasConceptScore W4387079785C2781197716 @default.
• W4387079785 hasConceptScore W4387079785C2909331925 @default.
• W4387079785 hasConceptScore W4387079785C43617362 @default.
• W4387079785 hasConceptScore W4387079785C55493867 @default.
• W4387079785 hasConceptScore W4387079785C71924100 @default.
• W4387079785 hasConceptScore W4387079785C98274493 @default.
• W4387079785 hasIssue "Supplement_1" @default.
• W4387079785 hasLocation W43870797851 @default.
• W4387079785 hasOpenAccess W4387079785 @default.
• W4387079785 hasPrimaryLocation W43870797851 @default.
• W4387079785 hasRelatedWork W1825955507 @default.
• W4387079785 hasRelatedWork W1919420982 @default.
• W4387079785 hasRelatedWork W1946026855 @default.
• W4387079785 hasRelatedWork W2016781223 @default.
• W4387079785 hasRelatedWork W2035421793 @default.
• W4387079785 hasRelatedWork W2038545176 @default.
• W4387079785 hasRelatedWork W2076662319 @default.
• W4387079785 hasRelatedWork W2414153668 @default.
• W4387079785 hasRelatedWork W2731465304 @default.
• W4387079785 hasRelatedWork W4299072964 @default.
• W4387079785 hasVolume "69" @default.
• W4387079785 isParatext "false" @default.
• W4387079785 isRetracted "false" @default.
• W4387079785 workType "article" @default.